Title: 
Headings: 

Content: Materials included in this Toolkit may not be modified, reproduced, or displayed for any commercial or public purpose without specific written permission from Children’s National Medical Center. Any copyrights and trademarks that are not the property of Children’s National Medical Center, which may also be referenced in this document, remain the property of their respective owners. D. Liability
Children’s National Medical Center does not warrant the content of this document and specifically disclaims, to the fullest extent permitted by law, any and all warranties, express or implied, of any kind or nature whatsoever. Neither Children’s National Medical Center nor any of its subsidiaries/programs shall be liable under any circumstances for any claims, losses, or causes of action that may arise from the use of this Toolkit or the information contained in it. User Agreement
Program Overview
Vision Pulse Oximetry Screening for Congenital Heart Disease: Who, What, When, Where, and Why? Opening Letter Screening Recommendations Letter to Providers Supplies for Screening Screening Form
Section 1Program Overview
CongHrt_Cover&Tabs9x11  10/11/11  12:56 PM  Page 3
Charles I. Berul, MD
Chief, Division of Cardiology Children's National Medical Center
This toolkit is an outstanding product that is the end result of much consideration and research, and will provide a straightforward, easy-to-use method to screen for cyanotic and serious forms of congenital heart disease in newborns. This program allows for a reliable, low-cost, high-throughput early detection program in the nursery setting, reducing the risks of complications from delayed diagnosis. I applaud the organizers and coordinators and hope that newborn pulse oximetry screening will quickly become widely implemented as standard of care. Through our expereince with research and helping hospitals to start CCHD screening programs in their nurseries we have learned a lot about best-practice for implementation.